p.S474N | TCGA-12-1598 | GBM | TCGA | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation rewiring degron network | 0.0833 |
p.S474N | DO10871 | GBM | ICGC | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation rewiring degron network | 0.0833 |
p.P492A | TCGA-13-1477 | OV | TCGA | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation altering degron motif | 0.7503 |
p.P492A | DO27978 | OV | ICGC | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation altering degron motif | 0.7503 |
p.A475T | TCGA-2W-A8YY | CESC | TCGA | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation rewiring degron network | 0.1111 |
p.A475T | DO223732 | CESC | ICGC | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation rewiring degron network | 0.1111 |
p.S502F | TCGA-EB-A5UN | SKCM | TCGA | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation rewiring degron network | 0.0556 |
p.S502F | DO47267 | SKCM | ICGC | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation rewiring degron network | 0.0556 |
p.D495N | TCGA-WE-A8K5 | SKCM | TCGA | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation rewiring degron network | 0.25 |
p.D495N | DO51282 | SKCM | ICGC | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation rewiring degron network | 0.25 |
p.D495N | SIDM00428 | Acute Myeloid Leukemia | GDSC | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation rewiring degron network | 0.25 |
p.D495N | ACH-000294 | Leukemia | CCLE | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation rewiring degron network | 0.25 |
p.D495N | NB-4 | haematopoietic and lymphoid tissue | COSMIC | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation rewiring degron network | 0.25 |
p.L491R | DO234406 | ESAD | ICGC | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation altering degron motif | 0.7316 |
p.T487I | DO231075 | LUSC | ICGC | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation altering degron motif | 0.5966 |
p.A484T | DO49118 | PACA | ICGC | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation altering degron motif | 0.6028 |
p.T476I | DO229221 | THCA | ICGC | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation rewiring degron network | 0.1389 |
p.P493S | SIDM00598 | Squamous Cell Lung Carcinoma | GDSC | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation rewiring degron network | 0.3056 |
p.P493S | ACH-000843 | Lung Cancer | CCLE | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation rewiring degron network | 0.3056 |
p.P493S | HARA | lung | COSMIC | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation rewiring degron network | 0.3056 |
p.A475P | SIDM00719 | Small Cell Lung Carcinoma | GDSC | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation rewiring degron network | 0.1111 |
p.A475P | ACH-001364 | Lung Cancer | CCLE | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation rewiring degron network | 0.1111 |
p.A475P | NCI-H345 | lung | COSMIC | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation rewiring degron network | 0.1111 |
p.T476K | SIDM00364 | B-Lymphoblastic Leukemia | GDSC | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation rewiring degron network | 0.1389 |
p.T476K | ACH-002059 | Leukemia | CCLE | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation rewiring degron network | 0.1389 |
p.T476K | P30-OHK | haematopoietic and lymphoid tissue | COSMIC | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation rewiring degron network | 0.1389 |
p.T501I | SIDM00251 | Gastric Carcinoma | GDSC | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation rewiring degron network | 0.0833 |
p.T501I | ACH-000949 | Gastric Cancer | CCLE | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation rewiring degron network | 0.0833 |
p.T501I | TGBC11TKB | stomach | COSMIC | NAQVTYSLLP | CBL_PTK | 483:492 | Mutation rewiring degron network | 0.0833 |